Barry A Love, MD
- ASSISTANT PROFESSOR | Pediatrics, Cardiology
- ASSISTANT PROFESSOR | Medicine, Cardiology
Specialties:Pediatrics, Pediatric Cardiology
Barry Love, MD is Assistant Professor in the Division of Cardiology in the Jack and Lucy Clark Department of Pediatrics at the Icahn School of Medicine at Mount Sinai and the Kravis Children's Hospital at Mount Sinai. He is the Director of the Congenital Cardiac Catheterization Laboratory at Mount Sinai Hospital. Dr. Love holds a joint appointment in both the Department of Pediatrics and the Department of Medicine and is one of only a few physicians who performs interventional procedures on patients with congenital heart disease from infancy through adulthood. He is board-certified in Pediatrics, Pediatric Cardiology as well as Adult Congenital Heart Disease.
Dr. Love has authored numerous papers and book chapters in congenital heart disease and adult congenital heart disease as well as interventional catheterization in congenital and structural heart disease. He has a research interest in new device technology and is a principal investigator for several device trials. Dr. Love has been a pioneer in extending many of the techniques used in the treatment of congenital heart disease, to acquired heart lesions in adults such as perivalvular leaks and post-infarction ventricular septal defects.
Areas of Expertise
Pediatric Interventional Catheterization, Electrophysiology and Arrhythmia, Syncope, and Adult Congenital Heart Disease
In the News
Dr. Love discusses pediatric heart problems in The Daily News feature The Daily Check Up.
View the PDF.
American Board of Pediatrics
- Adult congenital heart disease
MD, University of Western Ontario
Residency, Pediatrics, Children's Hospital of Montreal
Fellowship, Pediatric Cardiology, Children's Hospital Boston
- GORE Septal Occluder Clinical Study: A Study to evaluate safety and efficacy in treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs)
The purpose of this study is to determine the safety and effectiveness of the GORE Septal Occluder when used to close atrial septal defects. This study device is being evaluated to see if it will close ASDs without surgery. Researchers will look to see if the study...
- AMPLATZER Duct Occluder II in patients with a patent ductus arteriosus clinical study (ADO II Clinical Study)
The purpose of this study is to implant an experimental device called the AMPLATZER Duct Occluder II into a study participant's body to try to close their PDA. An experimental device is one that has not been approved by the U.S. Food and Drug Administration (FDA) for general u...
Triedman JK, Alexander ME, Love BA, Collins KK, Berul CI, Bevilacqua LM, Walsh EP. Influence of patient factors and ablative technologies on outcomes of radiofrequency ablation of intra-atrial reentrant tachycardia in patients with congenital heart disease. Journal of the American College of Cardiology 2002 June 5; 39(11): 1827-1835.
Gillis AM, Phillipon F, Cassidy MR, Singh N, Dorion P, Love BA, Kerr CR. Canadian Working Group on Cardiac Pacing. Guidelines for Implantable cardioverter defibrillator follow-up in Canada: a consensus. Statement of the Canadian Working Group on Cardiac Pacing. Canadian Journal of Cardiology 2003; 19(1): 21-37.